Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback

NCT05214833 is registered in ClinicalTrials.gov with ETH Zurich as lead sponsor.

NCT NCT05214833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05214833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback
Lead sponsor
ETH Zurich
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
January 31, 2025
Enrollment
225 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, temporal lobe, health, subjective, psychogenic seizure